Gerardo Cueto

Elevated plasma levels of IL-6 and MCP-1 selectively identify CML patients who better sustain molecular remission after TKI withdrawal

M. Bianchini, E. Levy, J. Mordoh, 2023, Journal of Hematology & Oncology.